Saad Usmani, MD, MBBS, MBA, of the Levine Cancer Institute/Carolinas HealthCare System, Charlotte, NC, talks on the accessibility and affordability of optimal therapies for patients with multiple myeloma. In particular, Dr Usmani comments on the need for innovation and partnerships between academic institutions and pharmaceuticals companies to reduce the cost of care in myeloma. This interview took place during the 18th International Myeloma Workshop (IMW 2021) congress.